Effects of chronic infusions of α-trinositol on regional and cardiac haemodynamics in conscious rats
Open Access
- 1 September 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 113 (1) , 129-136
- https://doi.org/10.1111/j.1476-5381.1994.tb16184.x
Abstract
1 Male, Long Evans rats (350–450 g) were chronically instrumented for the measurement of renal, mesenteric and hindquarters haemodynamics, and were given three consecutive, 24 h infusions of vehicle (sterile saline at 0.3 ml h−1; n = 8) or α-trinositol (d-mjyo-inositol-1,2,6-triphosphate) at 5, 20 and 80 mg kg−1 h−1 (0.3 ml h−1; n = 9). During infusion of α-trinositol at 5 or 20 mg kg−1 h−1, cardiovascular changes were little different from those seen during saline infusion. However, during infusion of α-trinositol at 80 mg kg−1 h−1 there were increases in hindquarters vascular conductance, renal flow and vascular conductance, that were all significantly different from the changes seen in the saline group. Infusion of α-trinositol at the high dose in naive rats (n = 8) had even more marked vasodilator effects. 2 Two groups of rats (n = 8 in each), chronically instrumented for the measurement of cardiac haemodynamics, were given 48 h infusions of saline (0.3 ml h−1) or α-trinositol (2 mg kg−1 bolus, 80 mg kg−1 h−1 infusion at 0.3 ml h−1). During the infusion of saline, there were slight reductions in heart rate, cardiac index, peak aortic flow, dF/dtmax and central venous pressure. In the animals receiving α-trinositol, with the exception of central venous pressure, all the above variables, together with total peripheral conductance, increased. 3 These results, collectively, indicate that incremental infusions of α-trinositol do not reveal its full vasodilator potential, possibly due to concurrent activation of counter-regulatory vasoconstrictor mechanisms. However, infusion of α-trinositol at a high dose causes substantial increases in renal, mesenteric and hindquarters flows and vascular conductances, supported by significant increases in indices of cardiac inotropism. Such effects, in the absence of significant hypotension, tachycardia or signs of desensitization, give α-trinositol a unique cardiovascular profile.Keywords
This publication has 22 references indexed in Scilit:
- Is PP56 (D-myo-inositol-1, 2, 6-triphosphate) an antagonist at neuropeptide Y receptors?Life Sciences, 1993
- D-myo-Inositol 1,2,6-triphosphate blocks neuropeptide Y-induced facilitation of noradrenaline-evoked vasoconstriction of the mesenteric bedEuropean Journal of Pharmacology, 1993
- Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetesEuropean Journal of Pharmacology, 1993
- Neuropeptide Y Inhibits Relaxation of Guinea Pig Cerebral, Coronary, and Uterine ArteriesJournal of Cardiovascular Pharmacology, 1992
- Differential effects of (±)‐dobutamine and human α‐CGRP on cardiac and on regional haemodynamics in conscious Long Evans ratsBritish Journal of Pharmacology, 1991
- Blockade of neuropeptide Y-induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol-1.2.6-trisphosphate (PP56) in rabbit femoral arteriesNeuropeptides, 1991
- Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin‐1 in conscious rats: effects of NG‐nitro‐l‐arginine methyl esterBritish Journal of Pharmacology, 1990
- Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteriesNeuropeptides, 1990
- An evaluation of derived aortic flow parameters as indices of myocardial contractility in ratsJournal of Pharmacological Methods, 1983
- Hemodynamic comparison of agents useful in hypertensive emergenciesAmerican Heart Journal, 1973